Custom Search
Showing posts with label people who use drugs. Show all posts
Showing posts with label people who use drugs. Show all posts

Feb 15, 2008

The Goa Declaration (INPUD Asia and the Pacific Region)


Link to INPUD website:


The Goa Declaration

By International Network of People Who Use Drugs

"Asia and the Pacific Region"

January 2008, India


Besides being the world's largest producer of opiates and other drugs such as Amphetamine type substances (ATS), the Asian and the pacific region is home to the largest number of drug users. Although evidence-based, cost-effective approaches are endorsed and promoted by various agencies people who use drugs in the region continue to be oppressed by discriminatory government policies and non-evidence based `solutions' to drug use, such as imprisonment and compulsory detoxification and rehabilitation. Without taking into consideration the socio-economic factors underpinning drug use in the region, people who use drugs will continue to be harassed, marginalised and discriminated against, stereotyped as dangerous and imprisoned.


The constant oppression, persecution and human rights violation contributes to HIV and hepatitis vulnerability of people who use drugs, particularly those who inject. In Asia, up to 89% of new HIV
and 92% of hepatitis C infections are occurring among injecting drug users (IDUs). On average IDUs account for 30-50% of new HIV infections and 40-60% of the IDU population is estimated to be living with hepatitis C virus (HCV) as well. Even though it is obvious that drug users' vulnerability to and experience with HIV and HCV make them one of the most important constituents in responses to HIV and HCV in Asia and the Pacific, the level of harm reduction, treatment, support services available as well as involvement of that particular community continues to be grossly insufficient.


If Asian and the Pacific governments, civil society, health care providers and other stakeholders are serious about halting the HIV/HCV epidemic, purposeful attention and action must be given to ensure evidence-based and non-oppressive approaches to address the needs and high vulnerability of the IDU population in Asia and the pacific. Policies on drug control need to be harmonized with HIV and HCV prevention, treatment, care and support efforts and standards of services for harm reduction would also be required in order to have an enabling environment for sustainable service delivery.


In this context, WE, the people who use drugs in Asia and the Pacific, thereby: Call on governments, various agencies, bi- and multilateral organisations, civil society organisations (CSOs) and the general public to support in:

  • Empowering our communities to advocate and protect our rights and to facilitate meaningful participation in decision making on issues affecting us;


  • Promoting a better understanding of current drug policies that negatively impact on the lives and rights of people who use drugs, their families and communities;


  • Acknowledging and enhancing our knowledge and skills to educate and train others, particularly our peers and members of our community;


  • Advocating for Universal Access to harm reduction, HIV/HCV treatment and care programmes, including access to evidence-based and effective drug treatment, appropriate medical care, safer consumption equipment, safe disposal of syringes and needles, up-to-date information about drugs and their effects, and safer facilities for practicing harm reduction;


  • Protecting and eexercising our right to evidence-based information on various drugs including their side effects and complications, access to equitable and comprehensive health and supportive social services, safe and affordable housing and meaningful employment opportunities;


  • Establishing specifically designed program to address the issues of women who use drugs and allocate enough resources to ensure programs are sustainable while actively promoting their meaningful full participation in all policy, program design and implementation process.


  • Supporting local, national and regional networks of people who use drugs are incorporated at all levels of decision-making and equitably remunerated for their contributions;


  • Challenging laws, policies and programmes that disempower, oppress and prevent us from leading healthy and positive lives;


  • Distinguishing drug dealers from people using drugs who need support, care and treatment instead of oppression and prosecution;


  • Providing easy access to affordable antiretroviral medicines including second and third line treatments, TB and HCV treatment for all who need them; if necessary by enacting intellectual property laws to protect the rights of developing countries to implement the safeguards enshrined in the TRIPS agreement and Doha Declarations such as Compulsory Licenses, as endorsed by the 2007 WHO General Assembly;


  • Advocating for development and adherence to harm reduction service delivery such as NSP, OST, residential care, ARV/HCV treatment etc.


Affirm our duties and responsibilities as responsible citizens in:


  • Contributing to collective efforts against the HIV and HCV epidemics in Asia and the Pacific, including HIV and HCV prevention, and care and support of those already infected and affected;


  • Seeking understanding of issues, challenges and needs of drug users in Asia and the Pacific;


  • Promoting tolerance, cooperation and collaboration; fostering a culture of inclusion and active participation;


  • Respecting the diversity of backgrounds, knowledge, skills and capabilities, and cultivating a safe and supportive environment within the drug user community regardless of the types and routes of drugs consumption;


  • Supporting, strengthening and encouraging the development of organizations for people who use drugs in communities/countries where they do not exist. State our position that:


  • The most profound need to establish a network of people who use drugs arises from the fact that no group of oppressed people ever attained liberation without the empowerment and involvement of those directly affected;


  • Through collective action, we will challenge existing oppressive drug laws, policies and programmes and work with government and our constituents to formulate evidence-based drug policies that respect human rights and dignity of people who use drugs.


Issued at the First Asian Consultation on the Prevention of HIV Related to Drug Use.

Goa, India on 31 January 2008.


contact for information:

INPUD Chairman Anan Pun (Nepal): ananpun@gmail.com

INPUD board member Fredy (Indonesia): fr_edy78@yahoo.com



WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore



Nov 29, 2007

The European Commission's reply to our letter 'Citizens request for an answer'


Dear friends and colleagues,


We received a reply to our letter for the European Commission 'Citizens request for an answer' (about the exclusion of people who use drugs in EU drugs policy making) from Mr. Carel Edwards, head of the EC's unit Drugs Policy Coordination. (read EC's reply below this message)


As you can read, Mister Edwards isn't answering to our questions.


We're now preparing a next reply and request for answers.


All the best,


Stijn Goossens
Executive Director

International Network Of People Who Use Drugs



Subject: Citizens request for an answer/INPUD

From: Carel.Edwards@ec.europa.eu

To: Stijn@inpud.org




(ref: DGJLS-C2/TJ/md/D(2007)16758)

Dear Mr Goossens,

Thank you very much for your message addressed to the European Commission and for your interest in the EU Civil Society Forum on Drugs.


As you have noticed, the total number of applicants for this Forum far exceeds the maximum number of participants set in the report on the open consultation on the Commission's Green Paper on the role of civil society in drugs policy in the European Union. Therefore, a selection had to be made, based on the criteria set out in the Green Paper itself and in the subsequent report, from among eligible organisations like yours. Organisations not selected at this point will be kept informed of all the activities of the Forum and may be considered for membership in the future.


As far as your organisation is concerned, we would like, in particular, to draw your attention to the criterion that the organisations participating should have a clear track record of activities and to point out that your organisation has only just been founded, earlier this year.


In response to your specific questions:


1) and 2) Many of the organisations selected represent the views of those "most directly concerned by the drugs problem", including drug users. Many of the organisations are aiming to reduce drug-related harm both to the individual and to society as a whole.


This is in line with one of the main conclusions drawn from the Green Paper and the subsequent report, namely that the Forum should represent a wide spectrum of views in a balanced way. As stated in the Green Paper, the objective of the Commission "is not to create a civil society assembly as a platform of various ideologies but to create a practical instrument to support policy formulation and implementation through practical advice".


3) The EU Drugs Strategy (2005-2013) and the EU Action Plan (2005-2008) call for an evidence-based, balanced and integrated approach on drugs. The Commission produces annual progress reports on implementation of the Action Plan and in 2008 it will conduct an evaluation of the current Action Plan with a view to proposing a new Action Plan for 2009-2013. Both the Strategy and the Action Plans fully respect the fundamental rights of EU citizens and the principles of law. Holding a structured dialogue with civil society at European level is one way of ensuring this.


I hope that you find these answers helpful. We look forward to a constructive dialogue with your organisation in the future.


Kind Regards,

Carel Edwards
EUROPEAN COMMISSION
______________________
Head of unit Drugs Policy Coordination
DG Justice, Freedom and Security
Mail: LX 46 01/83, BE 1049 Brussels
tel. + 32 2 295 95 38
__________________________
email: carel.edwards@ec.europa.eu


WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog

ArtCoreFromTheHardCore

Jul 13, 2007

Vancouver Canada: Chronic Addiction Substitution Treatment Trial






What is CAST?

Chronic Addiction Substitution Treatment Trial, or CAST, is a research trial that will work with addicted people to change their drug habits from illegal street drugs to legally available, orally-administered prescription medications. Health Canada must approve a Clinical Trial proposal for the research trials to use prescription medications in this innovative way. The research would analyze the effects on both the user’s health and the community at large. Regular interaction with health professionals will facilitate interventions to help users develop an “exit strategy” to end their drug dependency.

Video message from our Mayor

Measurable outcomes from the project for the community would include a reduction in the open drug market, a reduction in property crimes, and a reduction in aggressive panhandling and public nuisance complaints. Outcomes for the individual would be reduced illegal activity and subsequent arrests, increased level of housing options, increased health and increased employment opportunities.

Traditional drug addiction treatments have proven to be very successful for a large segment of people suffering from addiction. However, for roughly three quarters of the drug addicted population, traditional treatment has not resulted in abstinence in the long-term – substitution treatment offers an option for this population of illegal drug users. Ending drug dependency is the goal of substitution treatment.

>> Read more...

The Problem

Downtown Vancouver, in particular the area known as the Downtown Eastside (DTES), has become known for its large open drug scene, unsafe conditions for survival sex trade workers, violence, poor health outcomes and one of the most explosive HIV epidemics in North America. Despite decades of concerted interventions on the part of both the public and the private sector, people who live in, work in or visit this area remain at significant risk from both a health and a public order perspective.

Public illegal drug use, in particular the use of cocaine, is rampant; sex work remains visible and unsafe; addiction services are inadequate, poverty and homelessness are common – in fact, the rate of homelessness in the DTES has doubled in the past 5 years; and the HIV and HCV epidemics continue to grow. The average life expectancy for a man living in the downtown eastside is approximately 20 years less than in most other neighbourhoods in the city.

>> Read more...

Media

The CAST concept has been generating a lot of interest from the media.

>> Read what the media are saying...

Support

The CAST research trial and the concept behind the research is being supported by a wide range of people from all areas of society and across all political lines.

>> Read what supporters are saying...


WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore

Jul 4, 2007

Kongres za odvisnike

WWW.HaRdCOREhARMREdUCER.BE

Original article and interviews on the Vest website:

www.vest.si

2. julij 2007 ob 22:23 | Maja Čakarić |

V Cankarjevem domu v teh dneh gostijo prvi svetovni kongres o nadomestnem zdravljenju odvisnikov od prepovedanih drog. Tema srečanja, ki ga je pripravila jugovzhodna evropska mreža Seea, je torej razberljiva že iz zapisanega.

V soboto denimo so predstavili novo zdravilo suboxone, ki ga pri nas pričakujemo avgusta, in če gre verjeti raziskavam, in najbrž jim gre, je med njegovimi največjimi prednostmi, da povzroča manjšo odvisnost in manjše tveganje za razvoj tolerance na droge, zaradi manjše možnosti zlorabe pa je zdravilo primerno tudi za zdravljenje v zaporih. Na kongresu se bodo jutri pogovarjali še o predoziranju in spolno prenosljivih bolezni, sklenili pa ga bodo z vodenim ogledom mesta.

Andrej Kastelic, predsednik kongresa in SEEA net:

“Je pa globoko netolerantna do drugačnosti … Ta stopnja je tista, ki me žalosti.”

Stijn Goossens iz organizacije Inpud:

“Veliko ljudi bo trpelo, ampak nazadnje bodo ugotovili, da ni druge možnosti.”

Dolgo sem odvisen od amfetaminov. Uživati sem jih začel 1990, ko sem bil v belgijski vojski. Jemal sem jih vsak dan. Droge nikoli nisem injiciral. Ampak je pač ilegalna. Za Harmreduction sem delal v zatočišču za brezdomce v Antwerpnu in potem sem tam čez čas postal poklicno dejaven. Mislil sem si, da bi kaj takšnega lahko storil tudi zase, da bi se torej poskusil ubadati z lastno zasvojenostjo. Kar počnem, je vendar nelegalno, nikoli ne veš, kaj boš dobil. Je zelo stresno, ker ne veš, kje boš dobil drogo, je pa poceni in denar nikoli ni bil problem. Če si v organizaciji Harmreduction, veš, da ti lahko amfetamine predpišejo na recept, in to je seveda veliko bolje. Veš, kakšna je čistost, veš, da vselej dobiš isto količino. Ker ti jih predpišejo na recpet, veš, da jih boš vedno tudi dobil. Zato ni več stresno. Droga predpisana na recept odvisnika prikrajša za stres. Postane rutina in čez čas je kot zdravilo. Zjutraj vstanem, vzamem tablete in mi nanje ni treba misliti ves dan. Iz odvisništva preideš v rutino. In kot sem dejal, stresa ni več.

Nisem imel opravka z marginalizacijo, pač pa z netolerantnostjo. Nikoli nisem bil na cesti, imel sem nadzor nad svojim življenjem. Zdaj opazujem vrstnike, ki nimajo te možnosti. Naj se poskusijo organizirati. Potem bi lahko govorili o svojih težavah. Ne morem govoriti kot brezdomec ali odvisnik, ki si injicira droge. Nikoli ne govorim v prid odvisnikom, govorim kot odvisnik.

Nisem porabil veliko, približno 60 evrov na teden, ker je dovolj poceni.

Dobra praksa zdravljenje tistih, ki jemljejo droge? Imam težavo s centri, kamor prihajajo odvisniki. Sam imam družinskega zdravnika. Zato mi ni treba v center, kamor zahajajo vsi odvisniki. Tam si bolj številka kot oseba. Grem k svojemu družinskemu zdravniku. Tam sem še vedno tretiran kot oseba. Na tem želim delati v vseh centrih za odvisnike, torej na individualnem pristopu. Pomembno je, če želiš pomagati skupini … tam so vsi isti in nimaš občutka za razlike med posamezniki. Na tem občutku bi morali graditi.

Nisem še spoznal slovenskih odvisnikov. Jih bom pa nabrž danes popoldne ali zvečer. Z Mileno septembra organizirava Input srečanje v Sofiji, tja bova poskusila povabiti nekaj Slovencev, da bi delali za evropsko podružnico Inputa. Kot predstavnik civilne družbe bomo sodelovali z evropsko komisijo in ko bomo ta odnos vzpostavili, bo to za nas doma dobra referenca.

Sem iz Belgije. Politika do drog je zelo konservativna. Smo flamsko in francosko govoreči. Francoski so za Harmreduction delovanje, nizozemski so bolj starokopitni, konservatvni in zagovarjajo abstinenco od drog. Igle zamenjujemo komaj od leta 2000. To je noro. Še v Bolgariji jih zamenjujejo od konca 80. let.

Nimam občutka, da bi nam šlo bolje. Na koncu je neizogibno: Harmreduction bo prišel do tebe. Če se situacija slabša, ni druge možnosti. Počakali bomo. Veliko ljudi bo trpelo, ampak nazadnje bodo ugotovili, da druge možnosti ni.

Fragmenti z novinarske konference:

Andrej Kastelic: “Dr. Dubajić je dobro rekel: to je tako, kot bi od pacientov, ki se zdravijo zaradi depresije, zahteval, da najprej dvakrat naredijo samomor, poskušajo, potem jih bomo pa zdravil.”

- Sem na substitucijskem zdravljenju. Z dvema zdravnikoma iz Bolgarije - sem iz Bolgarije - smo se pogovarjali o tem, kar smo dosegli. Prepričana sem, da se sploh ne zavedate, kako pomembno delo sta opravili tukaj. Želim sporočiti vašim medijem, da je vaša država daleč pred vsemi, tudi mnogimi drugimi evropskimi državami, ki so vložile veliko truda in denarja, da so vzpostavile takšen sistem. Vi ste najboljši.

- To je izrazito pomemben dogodek ravno zaradi raziskav, ki smo jih opravili o nadomestnem zdravljenju, ne le na področju odvisnosti od opiatov, ampak tudi pri zdravljenju HIV in tudi pri zagotovitvi nege za paciente s HIV.

- Ta konferenca je zelo pomembna (prihajam iz NVO, ki se ukvarja zlasti z metadonsko terapijo). Ker sta si Makedonija in Slovenija precej podobni, lahko rečem, da je Slovenija vsaj dvajset let pred Makedonijo. Mi smo s to nadomestno metodo začeli prej, ampak ste v Sloveniji uvedli več drugih načinov nadomestnega zdravljenja, v Makedoniji pa še vedno poznamo le metadonskega in še ta ima omejen doseg. V glavnem mestu, v Skopju, ki ima 800 tisoč stanovalcev, novi pacienti, odvisniki, čakajo na zdravljenje z metadonom štiri leta. Nikogar ni, ki bi bi podprl nadomestno zdravljenje.

- To je nora situacija. Če ljudje pridejo v zapor, jih zdravijo z metadonom, ko pridejo ven … Zatečejo se v kriminial, samo zato, da pridejo v zapor.

- Zdravljenje v večini nadomestnih programov v Bolgariji, predvsem v Sofiji, je veliko dražje kot kupovanje heroina. Če hočeš ozdraveti, plačaš več. Dejstvo je, da živimo v regiji, kjer se HIV epidemija najhitreje razrašča. Pri vas imate več HIV zdravnikov kot uživalcev drog. Rešili ste že toliko življenj. Zame ste heroji.

Video: Maja Čakarić

Original article and interviews on the Vest website:
www.vest.si


WWW.HaRdCOREhARMREdUCER.BE
DrugWarLog
ArtCoreFromTheHardCore


Jun 29, 2007

Champ Solidarity Project: Nothing About Us Whitout Us


“Nothing About Us Without Us”

Drug users around the world organize for HIV and viral hepatitis
prevention, healthcare, and human rights


— Suzy Subways, Editor, Solidarity Project


We know that drug use—both legal and illegal—can increase a person’s HIV risk. We also know that just quitting drug use is not a realistic option for everyone. Harm reduction strategies accept that drug use is part of our world and provide effective tools to reduce the harmful effects that drug use can have, such as viral hepatitis, HIV and overdose. HIV, hepatitis C and hepatitis B can be transmitted when people share injecting equipment, so syringe exchanges give people clean, unused works and dispose of people’s used ones. Methadone is a drug that can be prescribed and taken orally so that injection is avoided completely, and many people find they can keep their lives more manageable and healthy with methadone or another type of opiate maintenance therapy. In this issue of Solidarity Project, we explore ways that drug users around the world are organizing to protect themselves and their communities when society won’t.

Ann Livingston (VANDU) and Tracy Swan (TAG)


At the 18th International Conference on the Reduction of Drug Related Harm in Warsaw, Poland in May, the Joint United Nations Programme on HIV/AIDS (UNAIDS) announced that about a third of people who contract HIV worldwide outside of Africa are exposed through shared syringes during injection drug use or indirectly as sexual partners of people infected through shared syringes.


The trend is similar in the United States, where these risk factors account for almost two-thirds of cumulative AIDS cases among women. Between 50-90%, of active and former injection drug users in the U.S. have hepatitis C (HCV), with most users becoming infected within the first years of beginning to inject. In Southeast Asia, Central Asia and Eastern Europe, injection drug use is a primary mode of transmission for both HIV and HCV. Yet only 8% of injection drug users worldwide have access to prevention services like opiate maintenance treatment and sterile syringes, according to UNAIDS.



The U.S.-led global “War on Drugs”—which puts drug users in the hands of police and prisons instead of serving users’ physical and mental health, housing, and recovery needs—increases the risk of contracting HIV and viral hepatitis, as well as the risk of overdose. Stijn Goossens, Director of Activism for the newly formed International Network of People who Use Drugs (INPUD) cites an example from his home, Antwerp, Belgium, to demonstrate the absurdity of making particular drugs illegal: “Antwerp jails are full of Moroccans in for the hash trade. How come they’re not full of Scottish people in for the whiskey trade?” Of course, Goossens and INPUD would oppose the incarceration of alcohol vendors from any country, but his point is clear.

Stijn Goossens (Inpud) and Grant McNally

User Activists


Even before the emergence of HIV, drug users organized to provide services for their communities and to defend their human rights. Those who are directly affected by an issue must lead every struggle for justice —and this struggle is no different. As with any movement, drug user organizing faces considerable challenges, but they can be overcome, especially with the logistical support of former and non-users.



A Movement Grows

Drug user organizing started in the Netherlands in the early 1970s to reduce the transmission of hepatitis B, and in 1984, a users’ group in Amsterdam began the first distribution of syringes to prevent HIV. The Drug User Organizing Manual, created by Jennifer Flynn for the Open Society Institute’s International Harm Reduction Development Program (IHRD), observes: “Heavily influenced by the AIDS movement, drug user organizing carries forward The Denver Principles, which rejects victimization and creates a new identity that individuals can call themselves, rather than being given a label by the outside world.”


Paul, Masia, Bijay, Sasha, Sam Inpud Activists


In the United Kingdom, says longtime activist Andria Efthimiou-Mordaunt, syringe exchange has never been illegal, and public health, especially mental health, has usually been prioritized over criminalizing users. “We’re bonkers. That is, sad or slightly mad, rather than bad or naughty,” she quips. She estimates that about a quarter of the opioid users in the UK receive methadone, and 1% are prescribed heroin as maintenance therapy. Although only about a tenth of users get all the services they need, these relatively liberal policies have shown results. Less than 2% of injection drug users in the UK have HIV, according to a March presentation at the United Nations Commission On Narcotic Drugs. Efthimiou-Mordaunt attributes this success to the influence of drug user groups. “For years, people in more recognized user groups have been covertly influencing policymakers, who phone us requesting information—data about, say, safer injection rooms. This is rare, but it does happen,” she says. “Some of them surely care, and want to be advised from the horse’s mouth. They know we’re right, but they can’t be seen to be advised by us.”

Recovering Nepal Nepal DU organization

Making Progress

By 2006, more than 65 countries had some kind of syringe distribution, and the volume of methadone prescribed globally had increased four times since the mid-1990s. Even Iran now provides clean syringes and methadone, and not only to the general public, but in prisons as well—one of only eight countries to do so.


In Canada, the Vancouver Area Network of Drug Users (VANDU) has about 1,500 members, hundreds of whom are actively engaged in the group’s efforts. Members visit each other in the hospital, attend nightly meetings to plan activist campaigns, and form alley patrols to check on users in the neighborhood. VANDU also launched North America’s only safe injection site—a safe, health-focused space where people can inject drugs and connect with healthcare professionals and addiction services. It has reduced drug overdoses and needle sharing, attracted users at risk for HIV and hepatitis C, and increased the number of users seeking treatment or counseling—without leading to increases in crime or drug use.


The Danish Drug Users’ Union, BrugerForeningen (BF), is one of the oldes t such groups. Methadone patients run BF’s daily drop-in center. The 630 members pay $18 in annual dues and can have free collective meals, laundry, vitamins, first aid and painkillers, and bicycle service. The also have access to computers and the Internet, physical workout equipment, painter and hobby rooms, musical instruments, video equipment, and copy and print services. BF members present preventive drug-education trainings to young people, nurses, journalists and other professionals. They also provide trainings to police cadets, substantially influencing the way police think of and treat drug users. BF’s Syringe Patrol clears the streets of used works, picking up more than 200,000 syringes and needles a year, and now gets paid by the city of Copenhagen to do so.


The group’s president, Jørgen Kjær, says, “We have done this citizen service on a voluntary basis for 10 years, and it is great now to be paid approximately $75,000 for a year’s work. Our next-door neighbors are a children’s library and the local citizen and culture house. Usually, user unions and most treatment institutions are hidden away along railway lines or harbor areas, but BF is right in the middle of Copenhagen, where we have rented 22-room premises in a community-owned building.”



Confronting Tough Challenges

This kind of integration with broader society is rare. Even in nearby Stockholm, Sweden, syringe exchange is illegal. On May 4, activists from the Swedish Users’ Union turned themselves in to the police to assess what the penalty would be. “We are handing out syringes for purely humanitarian reasons,” Berne Stålenkrantz, the union’s national chairman, told The Local, an online Swedish news service. “And we are forced to do so since society is not providing this type of healthcare.”


Johan and Berne
Swedish Users Union


INPUD’s Stijn Goossens praises their efforts and adds, “We are in a lucky position in Europe, because the consequences for this type of activity aren’t as severe as in the U.S. or Russia. That gives us some space to play with the system.”


The situation in the United States may not be nearly as bad as it is in China, which executes dozens of drug offenders each June to mark the United Nations International Day Against Drug Abuse and Illicit Trafficking. But the U.S. has become the greatest barrier to harm reduction worldwide and, of course, at home. In 2004, the State Department successfully pressured the United Nations Office on Drugs and Crime (UNODC) to stop supporting harm reduction. Two of the most relied-upon sources of HIV prevention funding in the world—the United States Agency for International Development (USAID) and the President’s Emergency Plan for AIDS Relief (PEPFAR)—refuse to fund syringe exchange. Nearly 200 syringe exchange programs operate in the United States, but this is still the only country in the world with an explicit ban on the use of federal funding for such programs. Several states still outlaw syringe exchange. All 50 states and Washington, DC, have some kind of syringe access — but even if it’s legal to buy them at pharmacies without a prescription, people can still go to jail for possessing them. If federal funding could be used to support syringe exchange programs, thousands of new HIV infections would be prevented each year.


The evidence shows it can be done. In an August 2006 essay, Roseanne Scotti, director of Drug Policy Alliance New Jersey, writes: “In other industrialized countries that implemented ‘sterile syringe access’ policies early on, the rate of HIV related to shared syringes is much lower: Australia, 4 percent; United Kingdom, 6 percent; Canada, 17 percent.” And in New York City, where community-based organizations have made harm reduction fairly accessible, the prevalence of HIV among injection drug users decreased from 50% in 1990 to 30% in 2000.


IDUSA
Indonesian User Activists


The war on drugs not only makes it difficult to prevent the transmission of HIV and hepatitis C, but it makes life much harder for those living with either or both of these viruses. About 2.3 million people are currently incarcerated in the United States—the highest rate in the world—and the dramatic increase over the past 30 years is primarily due to sentences for nonviolent drug offenders. Prison is no place to be if you’re HIVpositive, and it creates even more challenges if you have hepatitis C. Many prisoners are never tested for HCV despite the high prevalence among incarcerated populations, and few incarcerated people who need HCV treatment receive it.



Developing New Strategies

Many Americans find it hard to imagine their country as one of the most repressive in the world, but drug user and harm reduction activists know the realities all too well. Some are developing innovative strategies to fight back. In New York City, Voices of Community Advocates and Leaders (VOCAL) is organizing itself as a drug users’ union modeled on the users’ unions in Europe and Canada. Members pay dues, reach out to other users with information and safe injection kits, receive leadership training, and aim for seats on city planning committees and national advocacy groups related to HIV and harm reduction so that active users are not shut out of services—or the decisions made about those services.


As drug user activists worldwide put it: “Nothing about us without us.”

Many AIDS activist groups in the U.S. have empowered active users to fight for prevention services, housing, and health care. Some have active users in leadership positions, although the groups may not identify themselves as drug user organizations. These groups often look to alternative funding sources, such as benefit parties and other grassroots methods, in addition to applying for grants.


Dirk, Guy X, Stijn and Milena


The AIDS housing activist group and service provider Housing Works, also in New York City, has a catering service and thrift shops. These innovative ventures not only raise unrestricted income, but provide jobs for people who have a hard time finding work in a discriminatory environment due to a history of homelessness, drug use, or sex work, or simply because they’re transgender.


Louis Jones
Vocal


On May 13, at the 18th International Conference on the Reduction of Drug Related Harm, INPUD was formally launched after a year of internal development. With about 75 people in attendance, representing 26 countries and every continent but Africa, the network became a reality. One of its first projects will be to collaborate with the World Health Organization (WHO) to develop guidelines for conference organizers who welcome drug users on how to provide equipment for safer drug use to attendees who need it.


And after that? “I want to activate our professional harm reduction partners,” says INPUD organizer Stijn Goossens. “Harm reduction is pragmatic. But I think it should be pragmatic at the individual user level, not the policy level. If you’re going to be too pragmatic, with policy that hurts us, you will end up standing on the other side and fighting us.” Asked if he is saying that something more revolutionary is needed, Goossens replies, “It sounds revolutionary, but it’s all very logical.”


www.HaRdCOREhARMREdUCER.be
DrugWarLog
ArtCoreFromTheHardCore



Jun 28, 2007

Tolerantie Nu vs Zero Tolerance


or
Nederlands Party Scene in het verweer:
Tolerantie.nu vs zero tolerance

Er is nu een nieuwe website online, onder meer over vragen over politiecontroles op feesten.

Steeds vaker controleert of lijkt de politie te controleren op feesten. In het blauw of undercover in burger, dat maakt niet uit. Zelfs met het kleinste beetje drugs word je behandeld als een grote crimineel. Maar mensen weten helemaal niet wat de politie allemaal wel en niet mag. Daarom presenteerde de BVD, branchevereniging van dance organisatoren, gisteren in samenwerking met onder anderen Unity de website Tolerantie.nu. De site geeft informatie over wat je moet doen wanneer de politie iemand controleert op (vermeend) drugsbezit en/of –gebruik, maar probeert ook de grenzen in kaart te brengen van wat het opsporingsapparaat mag.

tolerantie site

Al sinds het begin de tijden hoort drugsgebruik bij het uitgaansleven. Dat werd jarenlang min of meer gedoogd door de overheid, maar daar is nu toch echt een einde aan gekomen. Iedereen herinnert zich vast nog wel de razzia’s op de Awakenings feesten in de Gashouder. Onder het motto Zero Tolerance zijn grootschalige politiecontroles en undercoveroperaties aan de orde van de dag. Maar mag de politie zomaar alles doen? Veel mensen hebben geen idee wat hun rechtspositie is.

Op Tolerantie.nu worden veel vragen beantwoord. Er komt een uitgebreid forum, waar mensen ervaringen en tips uit kunnen wisselen, er komt een pagina met veelgestelde vragen en de site werkt ook aan het geven van juridische bijstand aan bezoekers die op feesten door de politie zijn opgepakt voor (vermeend) drugsbezit en/of –gebruik. Tegenwoordig is iedereen die naar een feest gaat al bij voorbaat verdacht, of je nu clean bent of niet. Bezoekers worden geïntimideerd en gecriminaliseerd en weten zich daarin geen houding te geven. Met de info van de nieuwe site kun je je mondiger opstellen tegenover de dienders en meer voor jezelf en andere feestgangers opkomen.

Surf voor meer info naar www.tolerantie.nu.


HaRdCOREhARMREdUCER
ArtCoreFromTheHardCore



June 26th, Int. day against drug abuse & illicit trafficking. It's "against" that is the problem

HaRdCOREhARMREdUCER
ArtCoreFromTheHardCore




Manipur, India
June 26th, Int. day against drug abuse & illicit trafficking.


I just wanted to share my peronsel and our organization(MIVL)thoughts for this day.

The word "AGAINST" makes up the whole problem for us, to suffer, die and what else? Enough doing good for us,,,,,,,,,,, when its not working. This message is what we really need to convey to the international community who is incharge of us in our using business,,,INCB,,,UNODC...blah blah

If users are dying everyday from their policies and programmes what they are doing good for us.

Some years back, I was thrilled when june 26th comes closer and participated in many programs but recently I realized that june 26th is not our day to organize programs like non-user organization does,,, speaking about demand reduction, drug abuse prevention,,,... I really don't know why it took so long for me to realize the fact that the word "AGAINST" is so disempowering for the user community.

Our organization the Manipur Intravenous League(MIVL) organizes its 1st Remembrance Ceremony for lives lost to drugs on june 26th at the office hall of MIVL.

Our central Idea of having this ceremony is to remember those friends who lost their lives to drugs and most of all to dimnish this day june 26th forever "going against drug users,,,, they say drug abuse but its us, the user.

Its a beginning of a war we can win if we unite....

Regards,

Vikram

HaRdCOREhARMREdUCER
ArtCoreFromTheHardCore



New CEEHRN research, hepatitis C among injecting drug users




New CEEHRN study on hepatitis C among injecting drug users:
need for improved evidence-based and non-discriminatory policies and services


A new report entitled “Hepatitis C Among Injecting Drug Users in the New EU Member States and Neighboring Countries: Situation, Guidelines and Recommendations” shows that inadequate political commitment, prevention and neglected treatment interventions exist in the new EU member states, Russia and other Eastern European countries. In 13 of these countries, home to an estimated 2.1–3.3 million injecting drug users (IDUs), the prevalence of hepatitis C is as high as 70%-90% among IDUs, depending on the setting. At the same time, most IDUs do not have access to evidence-based prevention services and are systematically denied hepatitis C treatment, care and support.


The report, developed by the Central and Eastern European Harm Reduction Network (CEEHRN) in partnership with medical professionals and civil society representatives, summarizes the epidemic as well as governmental and local responses in 13 countries as well as evidence for hepatitis C prevention, treatment and support targeting drug users.


The growing hepatitis C epidemic could be managed by a commitment to address the needs of IDUs. The report calls for strengthening national advocacy efforts by raising awareness about the issue and building the capacity of health care specialists and service providers in order to enhance their knowledge and ensure non-discriminatory services and treatment practices. “Governments must take much more effective action now to prevent unnecessary deaths from this serious, but treatable disease. The biggest hurdle we are facing is that hepatitis C has not been made a priority”, said one of contributors Charles Gore of The Hepatitis C Trust. In order for hepatitis C to be put on the public health policy agenda, the report also calls on EU-wide hepatitis C actions.


***

Hepatitis C spreads rapidly among IDUs due to the high infectivity of the virus (about 10 times higher than HIV). Unlike HIV, it can be transmitted by sharing not only needles and syringes but also other injecting equipment (which comes into contact with and carries infected blood particles). Hepatitis C often presents no symptoms, and the vast majority of infected people are not aware of their status. This is even more common among IDUs, since a large part of this group is not reached by services and remains outside of the health care system. At the same time, hepatitis C presents a critical public health problem. Hepatitis C becomes chronic in about 85% of those infected, leading to liver disease like cirrhosis, liver failure and cancer. An estimated 250 000 people die annually of hepatitis C-related causes. Morbidity and mortality from HCV infection are expected to continue to risiein the coming decades. Yet only 2 out of the 13 countries studied have a strategy/program to manage hepatitis.


Access to prevention services for IDUs, including outreach, needle exchange and opioid substitution therapy varies across Europe and although better in Central than Eastern Europe, is still inadequate; in Russia the coverage might be as low as 2%. HCV testing and counseling is poorly linked to already established services for IDUs and is available at needle and syringe exchange and substitution therapy programs in only 5 countries, which also results in low hepatitis C literacy in IDUs communities.


In at least 9 out of 13 countries drug use is indicated as contraindication to hepatitis C treatment in treatment guidelines, with the exception of Slovenia, where hepatitis C treatment for drug users is recommended in cooperation between specialists in infectious diseases and drug addiction treatment. Even people undergoing drug substitution therapy are often declined treatment, while international guidelines state that drug users can not be excluded from treatment.


Further information:

Simona Merkinaite, Vilnius, Lithuania

Phone: +370 5 2609007

E-mail: simona@ceehrn.org

The electronic version of the report in English as well as Fact sheet with key facts and issues in English and Russian can be found at CEEHRN website at www.ceehrn.org/hepatitis.

Russian version of the report will also be available shortly. The information will be distributed separately. For printed copies, please write to simona@ceehrn.org.

With kind regards,

Simona Merkinaite

Central and Eastern European Harm Reduction Network

Address: Pamenkalnio 19-6, Vilnius 01114, Lithuania

Tel.: +370 5 2609007, 2691600

Fax: +370 5 2691601

Mob.: +370 6 8254401

E-mail: simona@ceehrn.org

Web: www.ceehrn.org


HaRdCOREhARMREdUCER
ArtCoreFromTheHardCore



 
Blog Directory - Blogged